论文部分内容阅读
国内外研究表明,干扰素(IFN)与拉米夫定(3TC)是目前治疗慢性乙型病毒性肝炎(CHB)的较为有效的抗病毒药物,我们比较联合或单独应用2种药物治疗CHB的疗效及不良反应,旨在探讨一种更为有效的治疗与护理方案。 1 材料与方法 1.1 病例来源 近年来在我院就诊的住院或门诊病人,符合1995年全国传染病与寄生虫病学术会议修订的CHB诊断标准。入选对象的年龄为16～65岁,HBV DNA阳性或HBsAg、
Domestic and foreign studies show that interferon (IFN) and lamivudine (3TC) is the current treatment of chronic hepatitis B (CHB) more effective antiviral drugs, we compare the combination of two drugs alone or in the treatment of CHB Efficacy and adverse reactions, to explore a more effective treatment and care programs. 1 Materials and Methods 1.1 Case Sources In recent years in our hospital for treatment of inpatients or outpatients, in line with the 1995 National Conference on Infectious Diseases and Parasitic Diseases revised CHB diagnostic criteria. Participants of the age of 16 to 65 years old, HBV DNA positive or HBsAg,